| |
| |
|
| Insider
Information: |
Mccourt Marion |
| Relationship: |
EVP Commercial |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
13,181 |
|
|
Indirect Shares
|
158 |
|
|
| Direct
Value |
$11,641,459 |
|
|
|
Indirect Value
|
$139,546 |
|
|
| Total
Shares |
13,339 |
|
|
| Total
Value |
$11,781,005 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 22.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medivation Inc |
MDVN |
Chief Operating Officer |
2016-09-28 |
0 |
2016-02-03 |
0 |
Premium* |
|
|
Regeneron Pharmaceuticals Inc |
REGN |
EVP Commercial |
2024-04-01 |
13,181 |
2024-04-01 |
158 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2024-04-01 |
4 |
AS |
$964.73 |
$241,183 |
D/D |
(250) |
13,181 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2024-03-01 |
4 |
AS |
$967.50 |
$346,365 |
D/D |
(358) |
13,431 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2024-02-05 |
4 |
S |
$934.71 |
$934,710 |
D/D |
(1,000) |
13,789 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2024-02-01 |
4 |
AS |
$945.61 |
$258,152 |
D/D |
(273) |
14,789 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2024-01-02 |
4 |
AS |
$873.91 |
$239,451 |
D/D |
(274) |
15,062 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-12-12 |
4 |
D |
$856.71 |
$4,373,505 |
D/D |
(5,105) |
15,336 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-12-11 |
4 |
D |
$844.09 |
$314,846 |
D/D |
(373) |
20,441 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-12-11 |
4 |
AS |
$838.44 |
$226,379 |
D/D |
(270) |
20,814 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,133 |
21,084 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-12-08 |
4 |
D |
$843.79 |
$718,909 |
D/D |
(852) |
18,951 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-11-01 |
4 |
AS |
$783.91 |
$783,910 |
D/D |
(1,000) |
19,803 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-11-01 |
4 |
OE |
$381.40 |
$381,400 |
D/D |
1,000 |
20,803 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-10-02 |
4 |
OE |
$372.46 |
$386,613 |
D/D |
1,038 |
20,841 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-10-02 |
4 |
AS |
$827.00 |
$858,426 |
D/D |
(1,038) |
19,803 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-09-01 |
4 |
AS |
$834.55 |
$208,638 |
D/D |
(250) |
19,803 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-08-01 |
4 |
AS |
$744.66 |
$186,165 |
D/D |
(250) |
20,053 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-07-03 |
4 |
AS |
$710.09 |
$177,523 |
D/D |
(250) |
20,303 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-06-01 |
4 |
AS |
$736.00 |
$184,000 |
D/D |
(250) |
20,553 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-04-03 |
4 |
AS |
$818.80 |
$900,680 |
D/D |
(1,100) |
20,803 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-04-03 |
4 |
OE |
$372.46 |
$409,706 |
D/D |
1,100 |
21,903 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-03-01 |
4 |
OE |
$372.46 |
$409,706 |
D/D |
1,100 |
21,903 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-03-01 |
4 |
AS |
$759.89 |
$835,879 |
D/D |
(1,100) |
20,803 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-02-12 |
4 |
D |
$751.78 |
$959,271 |
D/D |
(1,276) |
20,803 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-02-07 |
4 |
S |
$769.04 |
$769,040 |
D/D |
(1,000) |
22,079 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-02-07 |
4 |
OE |
$372.46 |
$372,460 |
D/D |
1,000 |
23,079 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
